IFNGR1 and neoplasm: To test this hypothesis, we inhibited IFNγ signaling using an anti-IFNγR1 blocking antibody or enhanced IFNγ secretion with a human recombinant interleukin-12 (huIL12) in our extended in vitro co-culture tumor cell killing assay (Fig. 2a).